Synthetic nucleic acids delivered by exosomes: A potential therapeutic for generelated metabolic brain diseases

Metabolic Brain Disease

Volumn 28, Issue 4, 2013, Pages 551-562

  Liu, Rutao ^a   Liu, Jing ^a   Ji, Xiaofei ^a   Liu, Yang ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Drug delivery system; Exosomes; Metabolic brain diseases; Nucleic acids

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID PRECURSOR PROTEIN; ANTISENSE OLIGONUCLEOTIDE; APOLIPOPROTEIN E4; BETA SECRETASE 1; CALCIUM; CEREBRAL DOPAMINE NEUROTROPHIC FACTOR; CHOLESTEROL; EXOSOMAL SHUTTLE RNA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HUNTINGTIN; LEVODOPA; MESSENGER RNA; MICRORNA; NEUROTROPHIC FACTOR; NUCLEIC ACID; OLIGONUCLEOTIDE; PARVOVIRUS VECTOR; POLYGLUTAMINE; REACTIVE OXYGEN METABOLITE; RECOMBINANT DNA; RNA; SMALL INTERFERING RNA; SPHINGOLIPID; SUCROSE; SYNDECAN; SYNTENIN; TAU PROTEIN; TETRASPANIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADENO ASSOCIATED VIRUS; ALZHEIMER DISEASE; ANTISENSE THERAPY; APOPTOSIS; ARTICLE; ASTROCYTE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN; BRAIN DISEASE; CELL ENCAPSULATION; CELL FATE; CELL MATURATION; CELL MEMBRANE; CYTOPLASM; DENDRITIC CELL; DOPAMINERGIC NERVE CELL; DRUG DELIVERY SYSTEM; ELECTROPORATION; EMBRYONIC STEM CELL; ENDOCYTOSIS; ENDOSOME; EXOSOME; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; GLIA CELL; HUMAN; HUNTINGTON CHOREA; LIPID RAFT; MAST CELL; MELANOMA CELL; MESENCHYMAL STEM CELL; METABOLIC ENCEPHALOPATHY; MITOCHONDRIAL RESPIRATION; NERVE CELL; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PERICYTE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUALITY OF LIFE; RESPIRATORY CHAIN; RNA INTERFERENCE; RNA TRANSLATION; T LYMPHOCYTE; ULTRACENTRIFUGATION; VIRAL GENE DELIVERY SYSTEM;

BRAIN DISEASES, METABOLIC; EXOSOMES; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; NUCLEIC ACIDS;

EID: 84887249207     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-013-9434-y     Document Type: Article

References (112)

1. Aguzzi A, O'Connor T (2010) Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov 9:237-248
2. Aliotta JM, Pereira M, Johnson KW, de Paz N, Dooner MS et al (2010) Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp Hematol 38(3):233-245
3. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341-345
4. Ambros V (2008) The evolution of our thinking about microRNAs. Nat Med 14:1036-1040
5. Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A et al (2013) Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res 10(3):301-312
6. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A (2012) Syndecan-syntenin-ALIX-regulates the biogenesis of exosomes. Nat Cell Biol 14(7):677-685
7. Batagov AO, Kuznetsov VA, Kurochkin IL (2011) Identification of nucleotide patterns enriched in secreted RNAsas putative cis-acting elements targeting them to exosome nano-vesicles. BMC Genom 12(Suppl 3):S18
8. Boudreau RL, Rodríguez-Lebrón E, Davidson BL (2011) RNAi medicine for the brain: progresses and challenges. Hum Mol Genet 20(R1):R21-R27
9. Büeler H (2009) Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol 218(2):235-246
10. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C (2005) Exosomal like vesicles are present in human blood plasma. Int Immunol 17:879-887
11. Castellani RJ, Rolston RK, Smith MA (2010) Alzheimer disease. Dis Mon 56(9):484-546
12. Chen TS, Lai RC, Lee MM, Choo ABH, Lee CN et al (2010) Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 38:215-224
13. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19:43-51
14. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L et al (2010) Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5(7):e11803
15. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA (2011) MicroRNAs in body fluids - the mix of hormones and biomarkers. Nat Rev Clin Oncol 8(8):467-477
16. Corti O, Lesage S, Brice A (2011) What genetics tells US about the causes and mechanisms of Parkinson's Disease. Physiol Rev 91:1161-1218
17. Dai S, Wei D, Wu Z et al (2008) Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 16:782-790
18. Deleavey GF, Damha MJ (2012) Designing chemically modified oligonucleic acid for targeted gene silencing. Chem Biol 19(8):937-954
19. Devi L, Ohno M (2012) Mitochondrial dysfunction and accumulation of the β-secretase cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice. Neurobiol Dis 45(1):417-424
20. Duchen MR (2012) Mitochondria, calcium-dependent neuronal death and neurodegenerative disease. Pflugers Arch - Eur J Physiol 464:111-121
21. Eketjäll S, Janson J, Jeppsson F, Svanhagen A, Kolmodin K et al (2013) AZ-4217: a high potency bace inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice. J Neurosci 33(24):10075-10084
22. Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495-516
23. Escudier B, Dorval T, Chaput N et al (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst Phase I clinical trial. J Transl Med 3:10
24. Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ et al (2010) Cellular internalization of exosomes occurs through phagocytosis. Traffic 11(5):675-687
25. Fonsato V, Collino F, Herrera MB, Cavallari C, Deregibus MC, Cisterna B (2012) Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor MicroRNAs. Stem Cells 30(9):1985-1998
26. Franich NR, Fitzsimons HL, Fong DM, Klugmann M, During MJ, Young D (2008) AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease. Mol Ther 16:947-956
27. Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105
28. Galindo MF et al (2010) Mitochondrial biology in Alzheimer's disease pathogenesis. J Neurochem 14:933-945
29. Gass J, Prudencio M, Stetler C, Petrucelli L (2012) Progranulin: an emerging target for FTLD therapies. Brainresearch 1462:118-128
30. Ge R, Tan E, Sharghi-Namini S, Asada HH (2012) Exosomes in cancer microenvironment and beyond: have we overlooked these extracellular messengers? Cancer Microenviron 5(3):323-332
31. Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA et al (2009) Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 20:363-379
32. Gravenfors Y, Viklund J, Blid J, Ginman T, Karlström S et al (2012) New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (Aβ) lowering in brain. J Med Chem 55(21):9297-9311
33. Gross JC, Chaudhary V, Bartscherer K, Boutros M (2012) Active Wnt proteins are secreted on exosomes. Nat Cell Biol 14(10):1036-1045
34. Gu Y, Li M, Wang T, Liang Y, Zhong Z, Wang X et al (2012) Lactation-related MicroRNA expression profiles of porcine breast milk exosomes. PLOS ONE 7:e43691
35. Hacein-Bey-Abina S, Hauer J, Lim A et al (2010) Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 363:355-364
36. Harper SQ, Staber PD, He X, Eliason SL, Martins IH et al (2005) RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc Natl Acad Sci U S A 102(16):5820-5825
37. Heng D, Guo L, Yan S, Sosunov AA et al (2010) Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. PNAS 107(43):18670-18675
38. Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D (2010) Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 14(6B):1605-1618
39. Hickey P, Stacy M (2013) AAV2-neurturin (CERE-120) for Parkinson's disease. Expert Opin Biol Ther 13(1):137-145
40. Honmou O, Houkin K, Matsunaga T, Niitsu Y, Ishiai S et al (2011) Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134(Pt 6):1790-1807
41. Houlden H, Singleton AB (2012) The genetics and neuropathology of Parkinson's disease. Acta Neuropathol 124:325-338
42. Hu J, Liu J, Corey DR (2010) Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism. Chem Biol 17:1183-1188
43. Huotari J, Helenius A (2011) Endosome maturation. The EMBO J 30:3481-3500
44. Kaiser J (2003) Gene therapy. Seeking the cause of induced leukemias in X-SCID trial. Science 299(5606):495
45. Kanasty RL, Whitehead KA, Vegas AJ, Anderson DG (2012) Action and reaction: the biological response to siRNA and its delivery vehicles. Mol Ther 20(3):513-524
46. Katakowski M, Buller B, Zheng X, Lu Y, Rogers T et al (2013) Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett 335(1):201-204
47. Katsuda T, Tsuchiya R, Kosaka N, Yoshioka Y, Takagaki K et al (2013) Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep 3:1197
48. Kim HS, Choi DY, Yun SJ, Choi SM, Kang JW et al (2012) Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res 11(2):839-849
49. Kole R, Krainer AR, Altman S (2012) RNA therapeutics: beyond RNA interference and antisense oligonucleic acid. Nat Rev Drug Discov 11(2):125-140
50. Kormann MS, Hasenpusch G, Aneja MK, Nica G, Flemmer AW, Herber-Jonat S et al (2011) Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol 29(2):154-157
51. Kuhn AN, Beiβert T, Simon P, Vallazza B, Buck J, Davies BP et al (2012) mRNA as a versatile tool for exogenous protein expression. Curr Gene Ther 12(5):347-361
52. Kumar P, Wu H, McBride JL, Jung KE, Kim MH et al (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448:39-43
53. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4(3):214-222
54. Lai RC, Yeo RW, Tan KH, Lim SK (2013) Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation. Regen Med 8(2):197-209
55. Laird FM, Cai H, Savonenko AV, Farah MH, He K et al (2005) BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci 25(50):11693-11709
56. Lamparski HG, Metha-Damani A, Yao JY, Patel S, Hsu DH, Ruegg C, Le Pecq JB (2002) Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods 270(2):211-226
57. Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E et al (2012) Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 126(22):2601-2611
58. Liu R, Wang S, Liu J (2013) Exosomes: the novel vehicles for intercellular communication. Progr Biochem Biophys 40(8):1-9
59. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ (2012a) ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 40(D1):D1241-D1244
60. Mathivanan S, Fahner CJ et al (2012b) ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 40(D1):D1241-D1244
61. Mazzulli JR, Xu YH, Sun Y, Knight AL, McLean PJ, Caldwell GA et al (2011) Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 46:37-52
62. Mizrak A, Bolukbasi MF, Ozdener GB, Brenner GJ, Madlener S et al (2013) Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Mol Ther 21(1):101-108
63. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML et al (2012) Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119(3):756-766
64. Murakami K, Murata N, Noda Y, Tahara S, Kaneko T et al (2011) SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease. J Biol Chem 286(52):44557-44568
65. Nolte-'t Hoen EN, Buermans HP, Waasdorp M, Stoorvogel W, Wauben MH, 't Hoen PA (2012) Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res 40(18):9272-9285
66. Ohno M, Cole SL, Yasvoina M, Zhao J, Citron M et al (2007) BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiol Dis 26:134-145
67. Ohno S, Takanashi M, Sudo K, Ueda S et al (2013) Systemically injected exosomes targeted to egfr deliver antitumor MicroRNA to breast cancer cells. Mol Ther 21(1):185-191
68. Olson SD, Kambal A, Pollock K, Mitchell GM, Stewart H, Kalomoiris S et al (2012) Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin. Mol Cell Neurosci 49:271-281
69. Pan Q, Ramakrishnaiah V, Henry S, Fouraschen S, de Ruiter PE et al (2012) Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Gut 61:1330-1339
70. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S et al (2009) Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 284(49):34211-34222
71. Peinado H, Alečković M, Lavotshkin S et al (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18(6):883-889
72. Perez-Hernandez D, Gutiérrez-Vázquez C, Jorge I, López-Martín S, Ursa A et al (2013) The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J Biol Chem 288(17):11649-11661
73. Quesenberry PJ, Aliotta JM (2010) Cellular phenotype switching and microvesicles. Adv Drug Deliv Rev 62(12):1141-1148
74. Rana S, Zöller M (2011) Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis. Biochem Soc Trans 39(2):559-562
75. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R et al (2006) Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20(5):847-856
76. Record M, Subra C, Silvente-Poirot S, Poirot M (2011) Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81:1171-1182
77. Reis LA, Borges FT, Simões MJ, Borges AA, Sinigaglia-Coimbra R, Schor N (2012) Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. PLoS One 7(9):e44092
78. Ren X, Zhang T, Gong X, Hu G, Ding W, Wang X (2013) AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model. Exp Neurol 248C:148-156
79. Ripa RS, Haack-Sørensen M, Wang Y, Jørgensen E, Mortensen S et al (2007) Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation 116(11 Suppl):I24-I30
80. Robbins M, Judge A, MacLachlan I (2009) siRNA and innate immunity. Oligonucleotides 19:89-102
81. Rodríguez-Lebrón E, Gouvion CM, Moore SA, Davidson BL, Paulson HL (2009) Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease. Mol Ther 17(9):1563-1573
82. Sahu R, Kaushik SC (2011) Microautophagy of cytosolic proteins by late endosomes. Dev Cell 20:131-139
83. Simons M, Raposo G (2009) Exosomes - vesicular carriers for intercellular communication. Curr Opin Cell Biol 21(4):575-581
84. Singer O, Marr RA, Rockenstein E, Crews L (2005) Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci 8:1343-1349
85. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L et al (2008) Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470-1476
86. Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B et al (2010) Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 16(2):198-204
87. Stuffers S, Sem WC, Stenmark H, Brech A (2009) Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic 10(7):925-937
88. Subra C, Laulagnier K, Perret B, Record M (2007) Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 89:205-212
89. Subra C, Grand D, Laulagnier K, Stella A, Lambeau G, Paillasse M et al (2010) Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res 51:2105-2120
90. Szabo TG, Misjak P, Aradi B et al. (2012) Comparative meta-analysis of proteomic data on extracellular vesicle subsets. F1000 Posters 3: 471
91. Tan J, Wu W, Xu X, Liao L, Zheng F et al (2012) Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 307(11):1169-1177
92. Tan A, Rajadas J, Seifalian AM (2013) Exosomes as nano-theranostic platforms for gene therapy. Adv Drug Deliv Rev 65(3):357-67
93. Théry C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2(8):569-579
94. Thery C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. doi: 10.1002/0471143030.cb0322s30
95. Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE et al (2007) Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 1(2):129-137
96. Turner JJ, Jones SW, Moschos SA, Lindsay MA, Gait MJ (2007) MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity. Mol Biosyst 3:43-50
97. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659
98. van den Boorn JG, Schlee M, Coch C, Hartmann G (2011) SiRNA delivery with exosome nanoparticles. Nat Biotechnol 29:325-326
99. van der Goot FG, Gruenberg J (2006) Intra-endosomal membrane traffic. Trends Cell Biol 16:514-521
100. van Niel G, Porto-Carreiro I, Simoes S, Raposo G (2006) Exosomes: a common pathway for a specialized function. J Biochem 140(1):13-21
101. Wahlgren J, De L, Karlson T, Brisslert M et al (2012) Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res 40(17):e130
102. Walsh DM, Selkoe DJ (2007) A beta oligomers - a decade of discovery. J Neurochem 101(5):1172-1184
103. Wang S, Cesca F, Loers G et al (2011) Synapsin I is an oligomannose-carrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via glia-derived exosomes. J Neurosci 31(20):7275-7290
104. Whitehead KA, Dahlman JE, Langer RS, Anderson DG (2011) Silencing or stimulation? siRNA delivery and the immune system. Annu Rev Chem Biomol Eng 2:77-96
105. Xia CF, Boado RJ, Zhang Y, Chu C, Pardridge WM (2008) Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter. J Gene Med 10(3):306-315
106. Xin H, Li Y, Buller B et al (2012) Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem cells 30(7):1556-1564
107. Xin H, Li Y, Liu Z, Wang X, Shang X, et al (2013) Mir-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotentmesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. doi: 10.1002/stem.1409
108. Xue YQ, Ma BF, Zhao LR, Tatom JB, Li B et al (2010) AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease. Gene Ther 17(1):83-94
109. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC et al (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402:533-537
110. Zamecnik PC, Stephenson ML (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A 75:280-284
111. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39(1):133-144
112. Zhang Y, Satterlee A, Huang L (2012) In vivo gene delivery by nonviral vectors: overcoming hurdles? Mol Ther 20(7):1298-1304